Symbols / CV Stock $6.07 +5.20% CapsoVision, Inc.

Healthcare • Medical Devices • United States • NCM
CV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Kang-Huai Wang
Exch · Country NCM · United States
Market Cap 302.52M
Enterprise Value 293.29M
Income -25.32M
Sales 13.55M
FCF (ttm) -13.01M
Book/sh 0.28
Cash/sh 0.20
Employees 99
Insider 10d —
IPO Jul 02, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 22.32
P/B 21.45
P/C —
EV/EBITDA -11.67
EV/Sales 21.64
Quick Ratio 2.85
Current Ratio 3.77
Debt/Eq 6.69
LT Debt/Eq —
EPS (ttm) -1.03
EPS next Y —
EPS Growth —
Revenue Growth 13.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-03-26
ROA -90.65%
ROE -184.95%
ROIC —
Gross Margin 52.92%
Oper. Margin -186.45%
Profit Margin -186.77%
Shs Outstand 49.84M
Shs Float 31.56M
Insider Own 36.91%
Instit Own 1.62%
Short Float 2.79%
Short Ratio 2.63
Short Interest 1.35M
52W High 15.37
vs 52W High -60.51%
52W Low 3.43
vs 52W Low 76.76%
Beta —
Impl. Vol. —
Rel Volume 0.27
Avg Volume 319.54K
Volume 84.74K
Target (mean) $10.50
Tgt Median $10.50
Tgt Low $10.00
Tgt High $11.00
# Analysts 2
Recom None
Prev Close $5.77
Price $6.07
Change 5.20%
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.50
Mean price target
2. Current target
$6.07
Latest analyst target
3. DCF / Fair value
$-4.70
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.07
Low
$10.00
High
$11.00
Mean
$10.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 main Benchmark Speculative Buy → Speculative Buy $10
2025-12-31 main Benchmark Speculative Buy → Speculative Buy $14
2025-07-28 init Benchmark — → Speculative Buy $5
News
RSS: Latest CV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-31 GOUW JULIA S Director — 2,887 $10.69 $30,862
2025-12-31 IMPERIAL JOANNE CAROL M.D. Director — 2,887 $10.69 $30,862
2025-12-31 KUO HUI YING Director — 2,887 $10.69 $30,862
2025-12-31 KING WEN-HERNG HENRY Director — 2,887 $10.69 $30,862
2025-12-31 TSAI CHEN LUNG Director — 2,887 $10.69 $30,862
2025-12-31 HARARI MICHELE Director — 2,887 $10.69 $30,862
2025-08-18 PETERSEN REBECCA ANN Officer — 24,834 $0.37 $9,097
2025-07-03 HARARI ELIYAHOU ET AL Beneficial Owner of more than 10% of a Class of Security — 4,222,422 — —
2025-07-03 KUO HUI YING Director — 10,354 — —
2025-07-03 KING WEN-HERNG HENRY Director — 20,710 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
13.55
+15.29%
11.76
+20.54%
9.75
Operating Revenue
13.55
+15.29%
11.76
+20.54%
9.75
Cost Of Revenue
6.38
+18.63%
5.38
+26.21%
4.26
Reconciled Cost Of Revenue
6.38
+18.63%
5.38
+26.21%
4.26
Gross Profit
7.17
+12.48%
6.38
+16.14%
5.49
Operating Expense
32.69
+24.32%
26.29
+56.16%
16.84
Research And Development
18.31
+21.10%
15.12
+62.01%
9.33
Selling General And Administration
14.38
+28.68%
11.17
+48.89%
7.50
Selling And Marketing Expense
7.53
+8.08%
6.97
+25.92%
5.53
General And Administrative Expense
6.85
+62.80%
4.21
+113.34%
1.97
Other Gand A
6.85
+62.80%
4.21
+113.34%
1.97
Total Expenses
39.07
+23.35%
31.67
+50.11%
21.10
Operating Income
-25.52
-28.11%
-19.92
-75.53%
-11.35
Total Operating Income As Reported
-25.52
-28.11%
-19.92
-75.53%
-11.35
EBITDA
-24.95
-28.63%
-19.40
-76.99%
-10.96
Normalized EBITDA
-24.95
-28.63%
-19.40
-76.99%
-10.96
Reconciled Depreciation
0.57
+8.83%
0.52
+34.28%
0.39
EBIT
-25.52
-28.11%
-19.92
-75.53%
-11.35
Net Income
-25.32
-27.22%
-19.90
-76.01%
-11.30
Pretax Income
-25.29
-27.17%
-19.89
-76.08%
-11.29
Net Non Operating Interest Income Expense
0.27
+934.62%
0.03
-46.94%
0.05
Net Interest Income
0.27
+934.62%
0.03
-46.94%
0.05
Interest Income Non Operating
0.27
+934.62%
0.03
-46.94%
0.05
Interest Income
0.27
+934.62%
0.03
-46.94%
0.05
Other Income Expense
-0.04
-1200.00%
0.00
+0.00%
0.00
Other Non Operating Income Expenses
-0.04
-1200.00%
0.00
+0.00%
0.00
Tax Provision
0.02
+118.18%
0.01
+0.00%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-25.32
-27.22%
-19.90
-76.01%
-11.30
Net Income From Continuing Operation Net Minority Interest
-25.32
-27.22%
-19.90
-76.01%
-11.30
Net Income From Continuing And Discontinued Operation
-25.32
-27.22%
-19.90
-76.01%
-11.30
Net Income Continuous Operations
-25.32
-27.22%
-19.90
-76.01%
-11.30
Normalized Income
-25.32
-27.22%
-19.90
-76.01%
-11.30
Net Income Common Stockholders
-25.32
-27.22%
-19.90
-76.01%
-11.30
Diluted EPS
—
-0.43
-46.69%
-0.29
Basic EPS
—
-0.43
-46.69%
-0.29
Basic Average Shares
—
46.34
+19.99%
38.62
Diluted Average Shares
—
46.34
+19.99%
38.62
Diluted NI Availto Com Stockholders
-25.32
-27.22%
-19.90
-76.01%
-11.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
18.16
+8.10%
16.80
-21.94%
21.53
Current Assets
16.67
+12.27%
14.85
-22.68%
19.20
Cash Cash Equivalents And Short Term Investments
10.11
+8.51%
9.32
-35.99%
14.56
Cash And Cash Equivalents
10.11
+8.51%
9.32
-35.99%
14.56
Cash Financial
10.11
+8.51%
9.32
-35.99%
14.56
Receivables
2.50
+24.84%
2.00
+7.23%
1.87
Accounts Receivable
2.50
+24.84%
2.00
+7.23%
1.87
Inventory
2.99
+13.62%
2.63
+19.77%
2.19
Raw Materials
1.89
+21.21%
1.56
+10.12%
1.41
Work In Process
0.99
+10.81%
0.90
+67.98%
0.53
Finished Goods
0.11
-39.20%
0.18
-29.03%
0.25
Prepaid Assets
0.62
+51.09%
0.41
+95.73%
0.21
Current Deferred Assets
0.00
-100.00%
0.23
0.00
Other Current Assets
0.45
+72.31%
0.26
-29.92%
0.37
Total Non Current Assets
1.50
-23.57%
1.96
-15.87%
2.33
Net PPE
1.45
-24.07%
1.92
-16.12%
2.28
Gross PPE
2.03
-10.77%
2.27
-6.65%
2.44
Accumulated Depreciation
-0.57
-60.17%
-0.36
-134.64%
-0.15
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
1.03
+11.61%
0.92
+2.79%
0.90
Other Properties
0.84
-29.46%
1.20
-20.86%
1.51
Leases
0.16
+0.00%
0.16
+441.38%
0.03
Other Non Current Assets
0.04
+0.00%
0.04
-2.38%
0.04
Total Liabilities Net Minority Interest
4.90
-96.65%
146.31
+11.37%
131.37
Current Liabilities
4.43
+145.81%
1.80
+19.51%
1.51
Payables And Accrued Expenses
2.75
+232.09%
0.83
+24.47%
0.67
Payables
1.22
+49.75%
0.82
+81.33%
0.45
Accounts Payable
1.14
+52.60%
0.75
+107.48%
0.36
Current Accrued Expenses
1.53
+11676.92%
0.01
-93.98%
0.22
Pensionand Other Post Retirement Benefit Plans Current
0.57
+62.75%
0.35
+13.31%
0.31
Total Tax Payable
0.08
+17.91%
0.07
-24.72%
0.09
Current Debt And Capital Lease Obligation
0.41
+16.81%
0.35
+27.17%
0.28
Current Capital Lease Obligation
0.41
+16.81%
0.35
+27.17%
0.28
Current Deferred Liabilities
0.18
+34.09%
0.13
+37.50%
0.10
Current Deferred Revenue
0.18
+34.09%
0.13
+37.50%
0.10
Other Current Liabilities
0.52
+270.71%
0.14
-13.04%
0.16
Total Non Current Liabilities Net Minority Interest
0.48
-99.67%
144.51
+11.28%
129.86
Long Term Debt And Capital Lease Obligation
0.48
-46.22%
0.89
-28.35%
1.24
Long Term Capital Lease Obligation
0.48
-46.22%
0.89
-28.35%
1.24
Preferred Securities Outside Stock Equity
0.00
-100.00%
143.62
+11.66%
128.62
Stockholders Equity
13.26
+110.24%
-129.51
-17.90%
-109.84
Common Stock Equity
13.26
+110.24%
-129.51
-17.90%
-109.84
Capital Stock
0.05
+2250.00%
0.00
+0.00%
0.00
Common Stock
0.05
+2250.00%
0.00
+0.00%
0.00
Preferred Stock
—
79.68
+23.19%
64.68
Share Issued
46.87
+1.12%
46.34
+0.00%
46.34
Ordinary Shares Number
46.87
+1.12%
46.34
+0.00%
46.34
Additional Paid In Capital
168.88
+20052.51%
0.84
+38.06%
0.61
Retained Earnings
-155.66
-19.42%
-130.35
-18.02%
-110.45
Total Equity Gross Minority Interest
13.26
+110.24%
-129.51
-17.90%
-109.84
Total Capitalization
13.26
+110.24%
-129.51
-17.90%
-109.84
Working Capital
12.24
-6.16%
13.05
-26.27%
17.70
Invested Capital
13.26
+110.24%
-129.51
-17.90%
-109.84
Total Debt
0.89
-28.35%
1.24
-18.23%
1.51
Capital Lease Obligations
0.89
-28.35%
1.24
-18.23%
1.51
Net Tangible Assets
13.26
+110.24%
-129.51
-17.90%
-109.84
Tangible Book Value
13.26
+110.24%
-129.51
-17.90%
-109.84
Preferred Stock Equity
—
79.68
+23.19%
64.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-22.86
-13.80%
-20.09
-85.99%
-10.80
Cash Flow From Continuing Operating Activities
-22.86
-13.80%
-20.09
-85.99%
-10.80
Net Income From Continuing Operations
-25.32
-27.22%
-19.90
-76.01%
-11.30
Depreciation Amortization Depletion
0.57
+8.83%
0.52
+34.28%
0.39
Depreciation
0.57
+8.83%
0.52
+34.28%
0.39
Depreciation And Amortization
0.57
+8.83%
0.52
+34.28%
0.39
Other Non Cash Items
0.03
—
—
Stock Based Compensation
0.83
+429.49%
0.16
+262.79%
0.04
Asset Impairment Charge
0.01
+37.50%
0.01
+100.00%
0.00
Operating Gains Losses
-0.17
-266.99%
0.10
+210.75%
-0.09
Net Foreign Currency Exchange Gain Loss
-0.17
-267.96%
0.10
+210.75%
-0.09
Gain Loss On Sale Of PPE
0.00
0.00
—
Change In Working Capital
1.19
+221.10%
-0.98
-709.32%
0.16
Change In Receivables
-0.48
-171.59%
-0.18
-2614.29%
0.01
Changes In Account Receivables
-0.48
-171.59%
-0.18
-2614.29%
0.01
Change In Inventory
-0.36
+17.51%
-0.43
+35.51%
-0.67
Change In Prepaid Assets
-0.17
+44.94%
-0.32
-140.36%
0.78
Change In Payables And Accrued Expense
2.50
+1260.87%
0.18
-39.47%
0.30
Change In Accrued Expense
2.13
+1143.14%
-0.20
-300.00%
0.10
Change In Payable
0.38
-3.09%
0.39
+92.08%
0.20
Change In Account Payable
0.38
-3.09%
0.39
+92.08%
0.20
Change In Other Working Capital
0.04
+25.00%
0.04
+63.64%
0.02
Change In Other Current Assets
0.00
-100.00%
0.00
+120.00%
-0.01
Change In Other Current Liabilities
-0.35
-27.17%
-0.28
+0.36%
-0.28
Investing Cash Flow
-0.09
+41.18%
-0.15
+79.71%
-0.75
Cash Flow From Continuing Investing Activities
-0.09
+41.18%
-0.15
+79.71%
-0.75
Net PPE Purchase And Sale
-0.09
+41.18%
-0.15
+79.71%
-0.75
Purchase Of PPE
-0.09
+41.18%
-0.15
+79.71%
-0.75
Capital Expenditure
-0.09
+41.18%
-0.15
+79.71%
-0.75
Financing Cash Flow
23.60
+56.59%
15.07
-26.57%
20.53
Cash Flow From Continuing Financing Activities
23.60
+56.59%
15.07
-26.57%
20.53
Net Issuance Payments Of Debt
0.00
0.00
—
Issuance Of Debt
1.00
0.00
—
Repayment Of Debt
-1.00
0.00
—
Long Term Debt Issuance
1.00
0.00
—
Long Term Debt Payments
-1.00
0.00
—
Net Long Term Debt Issuance
0.00
0.00
—
Net Common Stock Issuance
26.56
0.00
—
Proceeds From Stock Option Exercised
0.23
+212.16%
0.07
-57.47%
0.17
Net Other Financing Charges
-3.18
—
—
Changes In Cash
0.65
+112.57%
-5.17
-157.63%
8.97
Effect Of Exchange Rate Changes
0.14
+304.29%
-0.07
-289.19%
0.04
Beginning Cash Position
9.32
-35.99%
14.56
+162.28%
5.55
End Cash Position
10.11
+8.51%
9.32
-35.99%
14.56
Free Cash Flow
-22.95
-13.39%
-20.24
-75.18%
-11.56
Interest Paid Supplemental Data
0.01
0.00
—
Income Tax Paid Supplemental Data
0.01
+50.00%
0.01
+500.00%
0.00
Common Stock Issuance
26.56
0.00
—
Issuance Of Capital Stock
26.56
+77.05%
15.00
-26.31%
20.36
Net Preferred Stock Issuance
0.00
-100.00%
15.00
-26.31%
20.36
Preferred Stock Issuance
0.00
-100.00%
15.00
-26.31%
20.36
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category